Xigduo XR is a combination medication containing dapagliflozin, an SGLT2 inhibitor, and metformin hydrochloride, a biguanide. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both dapagliflozin and metformin is appropriate. The extended-release formulation allows for once-daily dosing, enhancing patient compliance. Dapagliflozin works by inhibiting glucose reabsorption in the kidneys, promoting urinary glucose excretion, while metformin decreases hepatic glucose production and improves insulin sensitivity. Clinical studies have shown that Xigduo XR effectively lowers HbA1c levels and may provide cardiovascular benefits. Common side effects include urinary tract infections, genital mycotic infections, and gastrointestinal disturbances. Regular monitoring of renal function is recommended during treatment. . Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
